Autosomal dominant tubulointerstitial kidney disease (ADTKD) refers to a group of disorders with a bland urinary sediment, slowly progressive chronic kidney disease (CKD), and autosomal dominant inheritance. Due to advances in genetic diagnosis, ADTKD is becoming increasingly recognized as a cause of CKD in both children and adults. ADTKD-REN presents in childhood with mild hypotension, CKD, hyperkalemia, acidosis, and anemia. ADTKD-UMOD is associated with gout and CKD that may present in adolescence and slowly progresses to kidney failure. HNF1β mutations often present in childhood with anatomic abnormalities such as multicystic or dysplastic kidneys, as well as CKD and a number of other extra-kidney manifestations. ADTKD-MUC1 is less common in childhood, and progressive CKD is its sole clinical manifestation, usually beginning in the late teenage years. This review describes the pathophysiology, genetics, clinical characteristics, diagnosis, and treatment of the different forms of ADTKD, with an emphasis on diagnosis. We also present data on kidney function in children with ADTKD from the Wake Forest Rare Inherited Kidney Disease Registry.

Pediatric Nephrology University of Texas Southwestern Medical Center 5323 Harry Hines Blvd Dallas TX 75390 0936 USA

Research Unit of Rare Diseases Department of Paediatrics and Inherited Metabolic Disorders 1st Faculty of Medicine Charles University Prague Czech Republic

Section on Nephrology Wake Forest School of Medicine Winston Salem NC 27157 USA

See more in PubMed

Devuyst O, Olinger E, Weber S, Eckardt KU, Kmoch S, Rampoldi L, Bleyer AJ (2019) Autosomal dominant tubulointerstitial kidney disease. Nat Rev Dis Primers 5:60.DOI 10.1038/s41572-019-0109-9 PubMed DOI

Bleyer AJ, Kidd K, Zivna M, Kmoch S (2017) Autosomal Dominant Tubulointerstitial Kidney Disease. Adv Chronic Kidney Dis 24:86–93.DOI S1548–5595(16)30140–9 [pii];10.1053/j.ackd.2016.11.012 [doi] PubMed DOI PMC

Hart TC, Gorry MC, Hart PS, Woodard AS, Shihabi Z, Sandhu J, Shirts B, Xu L, Zhu H, Barmada MM, Bleyer AJ (2002) Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet 39:882–892.DOI 10.1136/jmg.39.12.882 PubMed DOI PMC

Kirby A, Gnirke A, Jaffe DB, Baresova V, Pochet N, Blumenstiel B, Ye C, Aird D, Stevens C, Robinson JT, Cabili MN, Gat-Viks I, Kelliher E, Daza R, DeFelice M, Hulkova H, Sovova J, Vylet’al P, Antignac C, Guttman M, Handsaker RE, Perrin D, Steelman S, Sigurdsson S, Scheinman SJ, Sougnez C, Cibulskis K, Parkin M, Green T, Rossin E, Zody MC, Xavier RJ, Pollak MR, Alper SL, Lindblad-Toh K, Gabriel S, Hart PS, Regev A, Nusbaum C, Kmoch S, Bleyer AJ, Lander ES, Daly MJ (2013) Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat Genet 45:299–303.DOI 10.1038/ng.2543 PubMed DOI PMC

Heidet L, Decramer S, Pawtowski A, Moriniere V, Bandin F, Knebelmann B, Lebre AS, Faguer S, Guigonis V, Antignac C, Salomon R (2010) Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases. Clin J Am Soc Nephrol 5:1079–1090.DOI 10.2215/CJN.06810909 PubMed DOI PMC

Zivna M, Hulkova H, Matignon M, Hodanova K, Vylet’al P, Kalbacova M, Baresova V, Sikora J, Blazkova H, Zivny J, Ivanek R, Stranecky V, Sovova J, Claes K, Lerut E, Fryns JP, Hart PS, Hart TC, Adams JN, Pawtowski A, Clemessy M, Gasc JM, Gubler MC, Antignac C, Elleder M, Kapp K, Grimbert P, Bleyer AJ, Kmoch S (2009) Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure. Am J Hum Genet 85:204–213.DOI 10.1016/j.ajhg.2009.07.010 PubMed DOI PMC

Zivna M, Kidd K, Zaidan M, Vyletal P, Baresova V, Hodanova K, Sovova J, Hartmannova H, Votruba M, Treslova H, Jedlickova I, Sikora J, Hulkova H, Robins V, Hnizda A, Zivny J, Papagregoriou G, Mesnard L, Beck BB, Wenzel A, Tory K, Haeffner K, Wolf MTF, Bleyer ME, Sayer JA, Ong ACM, Balogh L, Jakubowska A, Laszkiewicz A, Clissold R, Shaw-Smith C, Munshi R, Haws RM, Izzi C, Capelli I, Santostefano M, Graziano C, Scolari F, Sussman A, Trachtman H, Decramer S, Matignon M, Grimbert P, Shoemaker LR, Stavrou C, Abdelwahed M, Belghith N, Sinclair M, Claes K, Kopel T, Moe S, Deltas C, Knebelmann B, Rampoldi L, Kmoch S, Bleyer AJ (2020) An International Cohort Study of Autosomal Dominant Tubulointerstitial Kidney Disease due to REN Mutations Identifies Distinct Clinical Subtypes. Kidney Int.DOI 10.1016/j.kint.2020.06.041 PubMed DOI PMC

Bleyer AJ, Kmoch S, Antignac C, Robins V, Kidd K, Kelsoe JR, Hladik G, Klemmer P, Knohl SJ, Scheinman SJ, Vo N, Santi A, Harris A, Canaday O, Weller N, Hulick PJ, Vogel K, Rahbari-Oskoui FF, Tuazon J, Deltas C, Somers D, Megarbane A, Kimmel PL, Sperati CJ, Orr-Urtreger A, Ben-Shachar S, Waugh DA, McGinn S, Bleyer AJ Jr., Hodanova K, Vylet’al P, Zivna M, Hart TC, Hart PS (2014) Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1. Clin J Am Soc Nephrol 9:527–535.DOI CJN.06380613 [pii];10.2215/CJN.06380613 [doi] PubMed DOI PMC

Wolf MT, Hildebrandt F (2011) Nephronophthisis. Pediatr Nephrol 26:181–194.DOI 10.1007/s00467-010-1585-z PubMed DOI PMC

Braun DA, Hildebrandt F (2017) Ciliopathies. Cold Spring Harb Perspect Biol 9.DOI 10.1101/cshperspect.a028191 PubMed DOI PMC

Wolf MT (2015) Nephronophthisis and related syndromes. Curr Opin Pediatr 27:201–211.DOI 10.1097/MOP.0000000000000194 PubMed DOI PMC

Stokman M, Lilien M, Knoers N (1993) Nephronophthisis. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mirzaa G, Amemiya A (eds) GeneReviews((R)), Seattle (WA). PubMed

Stokman MF, van der Zwaag B, van de Kar N, van Haelst MM, van Eerde AM, van der Heijden JW, Kroes HY, Ippel E, Schulp AJA, van Gassen KL, van Rooij I, Giles RH, Beales PL, Roepman R, Arts HH, Bongers E, Renkema KY, Knoers N, van Reeuwijk J, Lilien MR (2018) Clinical and genetic analyses of a Dutch cohort of 40 patients with a nephronophthisis-related ciliopathy. Pediatr Nephrol 33:1701–1712.DOI 10.1007/s00467-018-3958-7 PubMed DOI PMC

Georges B, Cosyns JP, Dahan K, Snyers B, Carlier B, Loute G, Pirson Y (2000) Late-onset renal failure in Senior-Loken syndrome. Am J Kidney Dis 36:1271–1275.DOI 10.1053/ajkd.2000.19845 PubMed DOI

Kidd K, Vylet’al P, Schaeffer C, Olinger E, Zivna M, Hodanova K, Robins V, Johnson E, Taylor A, Martin L, Izzi C, Jorge SC, Calado J, Torres RJ, Lhotta K, Steubl D, Gale DP, Gast C, Gombos E, Ainsworth HC, Chen YM, Almeida JR, de Souza CF, Silveira C, Raposeiro R, Weller N, Conlon PJ, Murray SL, Benson KA, Cavalleri GL, Votruba M, Vrbacka A, Amoroso A, Gianchino D, Caridi G, Ghiggeri GM, Divers J, Scolari F, Devuyst O, Rampoldi L, Kmoch S, Bleyer AJ (2020) Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations. Kidney Int Rep 5:1472–1485.DOI 10.1016/j.ekir.2020.06.029 PubMed DOI PMC

Moskowitz JL, Piret SE, Lhotta K, Kitzler TM, Tashman AP, Velez E, Thakker RV, Kotanko P (2013) Association between genotype and phenotype in uromodulin-associated kidney disease. Clin J Am Soc Nephrol 8:1349–1357.DOI CJN.11151012 [pii];10.2215/CJN.11151012 [doi] PubMed DOI PMC

Wolf MT, Beck BB, Zaucke F, Kunze A, Misselwitz J, Ruley J, Ronda T, Fischer A, Eifinger F, Licht C, Otto E, Hoppe B, Hildebrandt F (2007) The Uromodulin C744G mutation causes MCKD2 and FJHN in children and adults and may be due to a possible founder effect. Kidney Int 71:574–581.DOI 10.1038/sj.ki.5002089 PubMed DOI

Schaffer P, Gombos E, Meichelbeck K, Kiss A, Hart PS, Bleyer AJ (2010) Childhood course of renal insufficiency in a family with a uromodulin gene mutation. Pediatr Nephrol 25:1355–1360.DOI 10.1007/s00467-009-1436-y [doi] PubMed DOI PMC

Tramma D, Samourkasidou D (2020) Hyperuricemia and Early-onset Chronic Kidney Disease in a 7-year-old Child. Indian Pediatr 57:765. PubMed

Jain S, Chen F (2019) Developmental pathology of congenital kidney and urinary tract anomalies. Clin Kidney J 12:382–399.DOI 10.1093/ckj/sfy112 PubMed DOI PMC

Connaughton DM, Kennedy C, Shril S, Mann N, Murray SL, Williams PA, Conlon E, Nakayama M, van der Ven AT, Ityel H, Kause F, Kolvenbach CM, Dai R, Vivante A, Braun DA, Schneider R, Kitzler TM, Moloney B, Moran CP, Smyth JS, Kennedy A, Benson K, Stapleton C, Denton M, Magee C, O’Seaghdha CM, Plant WD, Griffin MD, Awan A, Sweeney C, Mane SM, Lifton RP, Griffin B, Leavey S, Casserly L, de Freitas DG, Holian J, Dorman A, Doyle B, Lavin PJ, Little MA, Conlon PJ, Hildebrandt F (2019) Monogenic causes of chronic kidney disease in adults. Kidney Int 95:914–928.DOI 10.1016/j.kint.2018.10.031 PubMed DOI PMC

Okorn C, Goertz A, Vester U, Beck BB, Bergmann C, Habbig S, Konig J, Konrad M, Muller D, Oh J, Ortiz-Bruchle N, Patzer L, Schild R, Seeman T, Staude H, Thumfart J, Tonshoff B, Walden U, Weber L, Zaniew M, Zappel H, Hoyer PF, Weber S (2019) HNF1B nephropathy has a slow-progressive phenotype in childhood-with the exception of very early onset cases: results of the German Multicenter HNF1B Childhood Registry. Pediatr Nephrol 34:1065–1075.DOI 10.1007/s00467-018-4188-8 PubMed DOI

Bleyer AJ, Kidd K, Robins V, Martin L, Taylor A, Santi A, Tsoumas G, Hunt A, Swain E, Abbas M, Akinbola E, Vidya S, Moossavi S, Bleyer AJ Jr., Zivna M, Hartmannova H, Hodanova K, Vyletal P, Votruba M, Harden M, Blumenstiel B, Greka A, Kmoch S (2019) Outcomes of patient self-referral for the diagnosis of several rare inherited kidney diseases. Genet Med.DOI 10.1038/s41436-019-0617-8 PubMed DOI PMC

Pottel H, Hoste L, Dubourg L, Ebert N, Schaeffner E, Eriksen BO, Melsom T, Lamb EJ, Rule AD, Turner ST, Glassock RJ, De Souza V, Selistre L, Mariat C, Martens F, Delanaye P (2016) An estimated glomerular filtration rate equation for the full age spectrum. Nephrol Dial Transplant 31:798–806.DOI 10.1093/ndt/gfv454 PubMed DOI PMC

Rampoldi L, Scolari F, Amoroso A, Ghiggeri G, Devuyst O (2011) The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease. Kidney Int 80:338–347.DOI ki2011134 [pii];10.1038/ki.2011.134 [doi] PubMed DOI

Tokonami N, Takata T, Beyeler J, Ehrbar I, Yoshifuji A, Christensen EI, Loffing J, Devuyst O, Olinger EG (2018) Uromodulin is expressed in the distal convoluted tubule, where it is critical for regulation of the sodium chloride cotransporter NCC. Kidney Int 94:701–715.DOI 10.1016/j.kint.2018.04.021 PubMed DOI

Vylet’al P, Kublova M, Kalbacova M, Hodanova K, Baresova V, Stiburkova B, Sikora J, Hulkova H, Zivny J, Majewski J, Simmonds A, Fryns JP, Venkat-Raman G, Elleder M, Kmoch S (2006) Alterations of uromodulin biology: a common denominator of the genetically heterogeneous FJHN/MCKD syndrome. Kidney Int 70:1155–1169.DOI 5001728 [pii];10.1038/sj.ki.5001728 [doi] PubMed DOI

Mutig K, Kahl T, Saritas T, Godes M, Persson P, Bates J, Raffi H, Rampoldi L, Uchida S, Hille C, Dosche C, Kumar S, Castaneda-Bueno M, Gamba G, Bachmann S (2011) Activation of the bumetanide-sensitive Na+,K+,2Cl− cotransporter (NKCC2) is facilitated by Tamm-Horsfall protein in a chloride-sensitive manner. J Biol Chem 286:30200–30210.DOI M111.222968 [pii];10.1074/jbc.M111.222968 [doi] PubMed DOI PMC

Trudu M, Janas S, Lanzani C, Debaix H, Schaeffer C, Ikehata M, Citterio L, Demaretz S, Trevisani F, Ristagno G, Glaudemans B, Laghmani K, Dell’Antonio G, team S, Loffing J, Rastaldi MP, Manunta P, Devuyst O, Rampoldi L (2013) Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression. Nat Med 19:1655–1660.DOI 10.1038/nm.3384 PubMed DOI PMC

Singh G, Lingala B, Mithal A (2019) Gout and hyperuricaemia in the USA: prevalence and trends. Rheumatology (Oxford) 58:2177–2180.DOI 10.1093/rheumatology/kez196 PubMed DOI

Moro F, Ogg CS, Simmonds HA, Cameron JS, Chantler C, McBride MB, Duley JA, Davies PM (1991) Familial juvenile gouty nephropathy with renal urate hypoexcretion preceding renal disease. Clin Nephrol 9:263–269 PubMed

Pavelka K Jr., Sebesta I, Blovska J, Maly J, Chadimova M (1996) [Familial juvenile gouty nephropathy]. Cas Lek Cesk 135:668–671 PubMed

Abhishek A, Valdes AM, Jenkins W, Zhang W, Doherty M (2017) Triggers of acute attacks of gout, does age of gout onset matter? A primary care based cross-sectional study. PLoS One 12:e0186096.DOI 10.1371/journal.pone.0186096 PubMed DOI PMC

Schaffer P, Gombos E, Meichelbeck K, Kiss A, Hart PS, Bleyer AJ (2010) Childhood course of renal insufficiency in a family with a uromodulin gene mutation. Pediatr Nephrol 25:1355–1360.DOI 10.1007/s00467-009-1436-y PubMed DOI PMC

Carucci NS, Caridi G, Lugani F, Barone C, Conti G (2019) A novel UMOD gene mutation associated with chronic kidney failure at a young age. Clin Nephrol 92:151–155.DOI 10.5414/CN109128 PubMed DOI

Wolf MT, Beck BB, Zaucke F, Kunze A, Misselwitz J, Ruley J, Ronda T, Fischer A, Eifinger F, Licht C, Otto E, Hoppe B, Hildebrandt F (2007) The Uromodulin C744G mutation causes MCKD2 and FJHN in children and adults and may be due to a possible founder effect. Kidney Int 71:574–581.DOI 5002089 [pii];10.1038/sj.ki.5002089 [doi] PubMed DOI

Stiburkova B, Bleyer AJ (2012) Changes in serum urate and urate excretion with age. Adv Chronic Kidney Dis 19:372–376.DOI S1548–5595(12)00147–4 [pii];10.1053/j.ackd.2012.07.010 [doi] PubMed DOI

Colantonio DA, Kyriakopoulou L, Chan MK, Daly CH, Brinc D, Venner AA, Pasic MD, Armbruster D, Adeli K (2012) Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem 58:854–868.DOI 10.1373/clinchem.2011.177741 PubMed DOI

Ridefelt P, Hilsted L, Juul A, Hellberg D, Rustad P (2018) Pediatric reference intervals for general clinical chemistry components - merging of studies from Denmark and Sweden. Scand J Clin Lab Invest 78:365–372.DOI 10.1080/00365513.2018.1474493 PubMed DOI

Bleyer AJ, Woodard AS, Shihabi Z, Sandhu J, Zhu H, Satko SG, Weller N, Deterding E, McBride D, Gorry MC, Xu L, Ganier D, Hart TC (2003) Clinical characterization of a family with a mutation in the uromodulin (Tamm-Horsfall glycoprotein) gene. Kidney Int 64:36–42.DOI 10.1046/j.1523-1755.2003.00081.x PubMed DOI

Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, Deltas C, Hosking A, Kmoch S, Rampoldi L, Wiesener M, Wolf MT, Devuyst O (2015) Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management-A KDIGO consensus report. Kidney Int.DOI ki201528 [pii];10.1038/ki.2015.28 [doi] PubMed DOI

Moro F, Simmonds HA, Cameron JS, Ogg CS, Williams GD, McBride MB, Davis PM (1991) Does Allopurinol affect the progression of familial juvenile gouty nephropathy? In: Harkness RA, al e (eds) Purine and Pyrimidine Metabolism in Man VII. Plenum Press, New York, pp 199–202. PubMed

Apostolopoulos V, Stojanovska L, Gargosky SE (2015) MUC1 (CD227): a multi-tasked molecule. Cell Mol Life Sci 72:4475–4500.DOI 10.1007/s00018-015-2014-z [doi];10.1007/s00018–015-2014-z [pii] PubMed DOI PMC

Hanisch FG, Muller S (2000) MUC1: the polymorphic appearance of a human mucin. Glycobiology 10:439–449.DOI 10.1093/glycob/10.5.439 PubMed DOI

Zivna M, Kidd K, Pristoupilova A, Baresova V, Defelice M, Blumenstiel B, Harden M, Conlon P, Lavin P, Connaughton DM, Hartmannova H, Hodanova K, Stranecky V, Vrbacka A, Vyletal P, Zivny J, Votruba M, Sovova J, Hulkova H, Robins V, Perry R, Wenzel A, Beck BB, Seeman T, Viklicky O, Rajnochova-Bloudickova S, Papagregoriou G, Deltas CC, Alper SL, Greka A, Bleyer AJ, Kmoch S (2018) Noninvasive Immunohistochemical Diagnosis and Novel MUC1 Mutations Causing Autosomal Dominant Tubulointerstitial Kidney Disease. J Am Soc Nephrol.DOI ASN.2018020180 [pii];10.1681/ASN.2018020180 [doi] PubMed DOI PMC

Dvela-Levitt M, Kost-Alimova M, Emani M, Kohnert E, Thompson R, Sidhom EH, Rivadeneira A, Sahakian N, Roignot J, Papagregoriou G, Montesinos MS, Clark AR, McKinney D, Gutierrez J, Roth M, Ronco L, Elonga E, Carter TA, Gnirke A, Melanson M, Hartland K, Wieder N, Hsu JC, Deltas C, Hughey R, Bleyer AJ, Kmoch S, Živná M, Barešova V, Kota S, Schlondorff J, Heiman M, Alper SL, Wagner F, Weins A, Golub TR, Lander ES, Greka A (2019) Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy. Cell 178:521–535.e523.DOI 10.1016/j.cell.2019.07.002 PubMed DOI

Wenzel A, Altmueller J, Ekici AB, Popp B, Stueber K, Thiele H, Pannes A, Staubach S, Salido E, Nuernberg P, Reinhardt R, Reis A, Rump P, Hanisch FG, Wolf MTF, Wiesener M, Huettel B, Beck BB (2018) Single molecule real time sequencing in ADTKD-MUC1 allows complete assembly of the VNTR and exact positioning of causative mutations. Sci Rep 8:4170.DOI 10.1038/s41598-018-22428-0 [doi];10.1038/s41598–018-22428–0 [pii] PubMed DOI PMC

Olinger E, Hofmann P, Kidd K, Dufour I, Belge H, Schaeffer C, Kipp A, Bonny O, Deltas C, Demoulin N, Fehr T, Fuster DG, Gale DP, Goffin E, Hodanova K, Huynh-Do U, Kistler A, Morelle J, Papagregoriou G, Pirson Y, Sandford R, Sayer JA, Torra R, Venzin C, Venzin R, Vogt B, Zivna M, Greka A, Dahan K, Rampoldi L, Kmoch S, Bleyer AJ, Devuyst O (2020) Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1. Kidney Int 98:717–731.DOI 10.1016/j.kint.2020.04.038 PubMed DOI

Knaup KX, Hackenbeck T, Popp B, Stoeckert J, Wenzel A, Buttner-Herold M, Pfister F, Schueler M, Seven D, May AM, Halbritter J, Grone HJ, Reis A, Beck BB, Amann K, Ekici AB, Wiesener MS (2018) Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition. J Am Soc Nephrol 29:2298–2309.DOI 10.1681/ASN.2018030245 PubMed DOI PMC

Dvela-Levitt M, Kost-Alimova M, Emani M, Kohnert E, Thompson R, Sidhom EH, Rivadeneira A, Sahakian N, Roignot J, Papagregoriou G, Montesinos MS, Clark AR, McKinney D, Gutierrez J, Roth M, Ronco L, Elonga E, Carter TA, Gnirke A, Melanson M, Hartland K, Wieder N, Hsu JC, Deltas C, Hughey R, Bleyer AJ, Kmoch S, Zivna M, Baresova V, Kota S, Schlondorff J, Heiman M, Alper SL, Wagner F, Weins A, Golub TR, Lander ES, Greka A (2019) Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy. Cell 178:521–535 e523.DOI 10.1016/j.cell.2019.07.002 PubMed DOI

Gribouval O, Gonzales M, Neuhaus T, Aziza J, Bieth E, Laurent N, Bouton JM, Feuillet F, Makni S, Ben Amar H, Laube G, Delezoide AL, Bouvier R, Dijoud F, Ollagnon-Roman E, Roume J, Joubert M, Antignac C, Gubler MC (2005) Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis. Nat Genet 37:964–968.DOI 10.1038/ng1623 PubMed DOI

Bleyer AJ, Zivná M, Hulková H, Hodanová K, Vyletal P, Sikora J, Zivný J, Sovová J, Hart TC, Adams JN, Elleder M, Kapp K, Haws R, Cornell LD, Kmoch S, Hart PS (2010) Clinical and molecular characterization of a family with a dominant renin gene mutation and response to treatment with fludrocortisone. Clin Nephrol 74:411–422.DOI 10.5414/cnp74411 PubMed DOI PMC

Kmoch S, Zivna M, Bleyer AJ (1993) Autosomal Dominant Tubulointerstitial Kidney Disease, REN-Related.DOI NBK53700 [bookaccession] PubMed PMC

Ferre S, Igarashi P (2019) New insights into the role of HNF-1beta in kidney (patho)physiology. Pediatr Nephrol 34:1325–1335.DOI 10.1007/s00467-018-3990-7 PubMed DOI PMC

Bockenhauer D, Jaureguiberry G (2016) HNF1B-associated clinical phenotypes: the kidney and beyond. Pediatr Nephrol 31:707–714.DOI 10.1007/s00467-015-3142-2 PubMed DOI

Adalat S, Woolf AS, Johnstone KA, Wirsing A, Harries LW, Long DA, Hennekam RC, Ledermann SE, Rees L, van’t Hoff W, Marks SD, Trompeter RS, Tullus K, Winyard PJ, Cansick J, Mushtaq I, Dhillon HK, Bingham C, Edghill EL, Shroff R, Stanescu H, Ryffel GU, Ellard S, Bockenhauer D (2009) HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol 20:1123–1131.DOI 10.1681/ASN.2008060633 PubMed DOI PMC

Raaijmakers A, Corveleyn A, Devriendt K, van Tienoven TP, Allegaert K, Van Dyck M, van den Heuvel L, Kuypers D, Claes K, Mekahli D, Levtchenko E (2015) Criteria for HNF1B analysis in patients with congenital abnormalities of kidney and urinary tract. Nephrol Dial Transplant 30:835–842.DOI 10.1093/ndt/gfu370 PubMed DOI

Faguer S, Chassaing N, Bandin F, Prouheze C, Garnier A, Casemayou A, Huart A, Schanstra JP, Calvas P, Decramer S, Chauveau D (2014) The HNF1B score is a simple tool to select patients for HNF1B gene analysis. Kidney Int 86:1007–1015.DOI S0085–2538(15)30417–8 [pii];10.1038/ki.2014.202 [doi] PubMed DOI

Kolbuc M, Lessmeier L, Salamon-Slowinska D, Malecka I, Pawlaczyk K, Walkowiak J, Wysocki J, Beck BB, Zaniew M (2020) Hypomagnesemia is underestimated in children with HNF1B mutations. Pediatr Nephrol 35:1877–1886.DOI 10.1007/s00467-020-04576-6 PubMed DOI

Gresh L, Fischer E, Reimann A, Tanguy M, Garbay S, Shao X, Hiesberger T, Fiette L, Igarashi P, Yaniv M, Pontoglio M (2004) A transcriptional network in polycystic kidney disease. EMBO J 23:1657–1668.DOI 10.1038/sj.emboj.7600160 [doi];7600160 [pii] PubMed DOI PMC

Verbitsky M, Westland R, Perez A, Kiryluk K, Liu Q, Krithivasan P, Mitrotti A, Fasel DA, Batourina E, Sampson MG, Bodria M, Werth M, Kao C, Martino J, Capone VP, Vivante A, Shril S, Kil BH, Marasa M, Zhang JY, Na YJ, Lim TY, Ahram D, Weng PL, Heinzen EL, Carrea A, Piaggio G, Gesualdo L, Manca V, Masnata G, Gigante M, Cusi D, Izzi C, Scolari F, van Wijk JAE, Saraga M, Santoro D, Conti G, Zamboli P, White H, Drozdz D, Zachwieja K, Miklaszewska M, Tkaczyk M, Tomczyk D, Krakowska A, Sikora P, Jarmolinski T, Borszewska-Kornacka MK, Pawluch R, Szczepanska M, Adamczyk P, Mizerska-Wasiak M, Krzemien G, Szmigielska A, Zaniew M, Dobson MG, Darlow JM, Puri P, Barton DE, Furth SL, Warady BA, Gucev Z, Lozanovski VJ, Tasic V, Pisani I, Allegri L, Rodas LM, Campistol JM, Jeanpierre C, Alam S, Casale P, Wong CS, Lin F, Miranda DM, Oliveira EA, Simoes ESAC, Barasch JM, Levy B, Wu N, Hildebrandt F, Ghiggeri GM, Latos-Bielenska A, Materna-Kiryluk A, Zhang F, Hakonarson H, Papaioannou VE, Mendelsohn CL, Gharavi AG, Sanna-Cherchi S (2019) The copy number variation landscape of congenital anomalies of the kidney and urinary tract. Nat Genet 51:117–127.DOI 10.1038/s41588-018-0281-y PubMed DOI PMC

Sanna-Cherchi S, Kiryluk K, Burgess KE, Bodria M, Sampson MG, Hadley D, Nees SN, Verbitsky M, Perry BJ, Sterken R, Lozanovski VJ, Materna-Kiryluk A, Barlassina C, Kini A, Corbani V, Carrea A, Somenzi D, Murtas C, Ristoska-Bojkovska N, Izzi C, Bianco B, Zaniew M, Flogelova H, Weng PL, Kacak N, Giberti S, Gigante M, Arapovic A, Drnasin K, Caridi G, Curioni S, Allegri F, Ammenti A, Ferretti S, Goj V, Bernardo L, Jobanputra V, Chung WK, Lifton RP, Sanders S, State M, Clark LN, Saraga M, Padmanabhan S, Dominiczak AF, Foroud T, Gesualdo L, Gucev Z, Allegri L, Latos-Bielenska A, Cusi D, Scolari F, Tasic V, Hakonarson H, Ghiggeri GM, Gharavi AG (2012) Copy-number disorders are a common cause of congenital kidney malformations. Am J Hum Genet 91:987–997.DOI 10.1016/j.ajhg.2012.10.007 PubMed DOI PMC

van der Ven AT, Connaughton DM, Ityel H, Mann N, Nakayama M, Chen J, Vivante A, Hwang DY, Schulz J, Braun DA, Schmidt JM, Schapiro D, Schneider R, Warejko JK, Daga A, Majmundar AJ, Tan W, Jobst-Schwan T, Hermle T, Widmeier E, Ashraf S, Amar A, Hoogstraaten CA, Hugo H, Kitzler TM, Kause F, Kolvenbach CM, Dai R, Spaneas L, Amann K, Stein DR, Baum MA, Somers MJG, Rodig NM, Ferguson MA, Traum AZ, Daouk GH, Bogdanovic R, Stajic N, Soliman NA, Kari JA, El Desoky S, Fathy HM, Milosevic D, Al-Saffar M, Awad HS, Eid LA, Selvin A, Senguttuvan P, Sanna-Cherchi S, Rehm HL, MacArthur DG, Lek M, Laricchia KM, Wilson MW, Mane SM, Lifton RP, Lee RS, Bauer SB, Lu W, Reutter HM, Tasic V, Shril S, Hildebrandt F (2018) Whole-Exome Sequencing Identifies Causative Mutations in Families with Congenital Anomalies of the Kidney and Urinary Tract. J Am Soc Nephrol 29:2348–2361.DOI 10.1681/ASN.2017121265 PubMed DOI PMC

Urakami T (2019) Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment. Diabetes Metab Syndr Obes 12:1047–1056.DOI 10.2147/DMSO.S179793 PubMed DOI PMC

Bolar NA, Golzio C, Zivna M, Hayot G, Van HC, Schepers D, Vandeweyer G, Hoischen A, Huyghe JR, Raes A, Matthys E, Sys E, Azou M, Gubler MC, Praet M, Van CG, McFadden K, Pediaditakis I, Pristoupilova A, Hodanova K, Vyletal P, Hartmannova H, Stranecky V, Hulkova H, Baresova V, Jedlickova I, Sovova J, Hnizda A, Kidd K, Bleyer AJ, Spong RS, Vande WJ, Mortier G, Brunner H, Van LL, Kmoch S, Katsanis N, Loeys BL (2016) Heterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia. Am J Hum Genet 99:174–187.DOI S0002–9297(16)30199–9 [pii];10.1016/j.ajhg.2016.05.028 [doi] PubMed DOI PMC

Espino-Hernandez M, Palma Milla C, Vara-Martin J, Gonzalez-Granado LI (2020) De novo SEC61A1 mutation in autosomal dominant tubulo-interstitial kidney disease: Phenotype expansion and review of literature. J Paediatr Child Health.DOI 10.1111/jpc.15148 PubMed DOI

Van Nieuwenhove E, Barber JS, Neumann J, Smeets E, Willemsen M, Pasciuto E, Prezzemolo T, Lagou V, Seldeslachts L, Malengier-Devlies B, Metzemaekers M, Hassdenteufel S, Kerstens A, van der Kant R, Rousseau F, Schymkowitz J, Di Marino D, Lang S, Zimmermann R, Schlenner S, Munck S, Proost P, Matthys P, Devalck C, Boeckx N, Claessens F, Wouters C, Humblet-Baron S, Meyts I, Liston A (2020) Defective Sec61alpha1 underlies a novel cause of autosomal dominant severe congenital neutropenia. J Allergy Clin Immunol 146:1180–1193.DOI 10.1016/j.jaci.2020.03.034 PubMed DOI PMC

Schubert D, Klein MC, Hassdenteufel S, Caballero-Oteyza A, Yang L, Proietti M, Bulashevska A, Kemming J, Kuhn J, Winzer S, Rusch S, Fliegauf M, Schaffer AA, Pfeffer S, Geiger R, Cavalie A, Cao H, Yang F, Li Y, Rizzi M, Eibel H, Kobbe R, Marks AL, Peppers BP, Hostoffer RW, Puck JM, Zimmermann R, Grimbacher B (2018) Plasma cell deficiency in human subjects with heterozygous mutations in Sec61 translocon alpha 1 subunit (SEC61A1). J Allergy Clin Immunol 141:1427–1438.DOI 10.1016/j.jaci.2017.06.042 PubMed DOI PMC

Kamath BM, Baker A, Houwen R, Todorova L, Kerkar N (2018) Systematic Review: The Epidemiology, Natural History, and Burden of Alagille Syndrome. J Pediatr Gastroenterol Nutr 67:148–156.DOI 10.1097/MPG.0000000000001958 PubMed DOI PMC

Kamath BM, Podkameni G, Hutchinson AL, Leonard LD, Gerfen J, Krantz ID, Piccoli DA, Spinner NB, Loomes KM, Meyers K (2012) Renal anomalies in Alagille syndrome: a disease-defining feature. Am J Med Genet A 158A:85–89.DOI 10.1002/ajmg.a.34369 PubMed DOI PMC

Reardon W, Casserly LF, Birkenhager R, Kohlhase J (2007) Kidney failure in Townes-Brocks syndrome: an under recognized phenomenon? Am J Med Genet A 143A:2588–2591.DOI 10.1002/ajmg.a.31699 PubMed DOI

Bleyer AJ, Hart PS, Kmoch S (2010) Hereditary interstitial kidney disease. Semin Nephrol 30:366–373.DOI 10.1016/j.semnephrol.2010.06.003 PubMed DOI PMC

Lemos MC, Thakker RV (2020) Hypoparathyroidism, deafness, and renal dysplasia syndrome: 20 Years after the identification of the first GATA3 mutations. Hum Mutat 41:1341–1350.DOI 10.1002/humu.24052 PubMed DOI

Rasmussen M, Nielsen ML, Manak JR, Mogensen H, Lildballe DL (2021) PAX2 variant associated with bilateral kidney agenesis and broad intrafamilial disease variability. Clin Kidney J 14:704–706.DOI 10.1093/ckj/sfaa013 PubMed DOI PMC

Connor TM, Hoer S, Mallett A, Gale DP, Gomez-Duran A, Posse V, Antrobus R, Moreno P, Sciacovelli M, Frezza C, Duff J, Sheerin NS, Sayer JA, Ashcroft M, Wiesener MS, Hudson G, Gustafsson CM, Chinnery PF, Maxwell PH (2017) Mutations in mitochondrial DNA causing tubulointerstitial kidney disease. PLoS Genet 13:e1006620.DOI 10.1371/journal.pgen.1006620 PubMed DOI PMC

Autosomal dominant tubulointerstitial kidney disease: A review